LMAT
LEMAITRE VASCULAR INC
$96.59
+1.56%
$2.2B
No data for this timeframe.
Vol
Market Cap$2.2B
Cap SizeMid Cap
Analyst ConsensusBuy (67%)
Inst. Holders8 funds
Inst. Value$224.0M
Inst. Activity2 buys / 0 sells
Insider Activity0B / 9S
Insider Net $-$8.0M
SEC Reports9
Recent Activity
Jun 4, 2026
Insider
Jasinski Lawrence J sold 0.466 shares
Director @ $0.00 ($0.00)
Jun 4, 2026
Insider
Roush John A sold 0.466 shares
Director @ $0.00 ($0.00)
Jun 4, 2026
Insider
O'Connor John James sold 0.466 shares
Director @ $0.00 ($0.00)
May 20, 2026
other
LeMaitre to Participate at Upcoming Investor Conferences in June
<p>BURLINGTON, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) annou
May 11, 2026
SEC
Three LeMaitre Vascular insiders, including CEO George LeMaitre, sold a total of $3.0M in open-market shares within a we
CLUSTER — Impact 4/10
May 11, 2026
SEC
Three insiders at LeMaitre Vascular sold a total of $1.31M in open-market sales within a week of the company reporting s
CLUSTER — Impact 2/10
May 11, 2026
SEC
Two directors at LeMaitre Vascular sold a combined $994K in open-market sales on May 7, 2026, following the company's st
CLUSTER — Impact 3/10
Inst.
TWO SIGMA INVESTMENTS, LP — DOUBLED
143,308 shares ($11.6M)
Price Targets
$118.75
+22.9% upside
Strong Buy
Current $96.59
Low $102.00
Median $120.00
High $135.00
8 analysts
$102.00
$135.00
Analyst Ratings
5Strong Buy
5Buy
5Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 3, 2026 | Barrington Research | MAINTAIN | Outperform → Outperform |
| May 6, 2026 | Barrington Research | MAINTAIN | Outperform → Outperform |
| May 6, 2026 | Citizens | MAINTAIN | Market Outperform → Market Outperform |
| May 6, 2026 | Wells Fargo | MAINTAIN | Equal-Weight → Equal-Weight |
| Feb 26, 2026 | Barrington Research | MAINTAIN | Outperform → Outperform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.81 ▲ +6.7% | $0.79 — $0.82 | 34% YoY | 9 |
| Next Q | $0.73 ▲ +1.7% | $0.69 — $0.77 | -2% YoY | 9 |
| Current FY | $3.00 ▲ +3.4% | $2.93 — $3.05 | 19% YoY | 9 |
| Next FY | $3.26 ▲ +2.2% | $3.16 — $3.34 | 9% YoY | 9 |
Latest Reports
BEARISH
CLUSTER
4/10
Three LeMaitre Vascular insiders, including CEO George LeMaitre, sold a total of $3.0M in open-market shares within a we
May 11, 2026
NEUTRAL
CLUSTER
2/10
Three insiders at LeMaitre Vascular sold a total of $1.31M in open-market sales within a week of the company reporting s
May 11, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $131.5M | — |
| MORGAN STANLEY | $35.8M | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $15.9M | NEW |
| RENAISSANCE TECHNOLOGIES LLC | $14.6M | — |
| TWO SIGMA INVESTMENTS, LP | $11.6M | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 4, 2026 | Jasinski Lawrence | A | $0.00 |
| Jun 4, 2026 | Roush John | A | $0.00 |
| Jun 4, 2026 | O'Connor John | A | $0.00 |
| Jun 4, 2026 | SHADAN MARTHA | A | $0.00 |
| Jun 4, 2026 | Pellegrino Joseph | A | $0.00 |
8 institutional holders with $224.0M total value (2,761,568 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, CHARLES. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 1,622,033 | $131.5M | 58.7% | — |
| 2 | MORGAN STANLEY | 440,933 | $35.8M | 16.0% | — |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 196,328 | $15.9M | 7.1% | NEW |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 180,502 | $14.6M | 6.5% | — |
| 5 | TWO SIGMA INVESTMENTS, LP | 143,308 | $11.6M | 5.2% | DOUBLED +125.8% |
| 6 | BANK OF AMERICA CORP /DE/ | 129,598 | $10.5M | 4.7% | ADD +30.5% |
| 7 | WELLS FARGO & COMPANY/MN | 42,821 | $3.5M | 1.6% | ADD +30.5% |
| 8 | FMR LLC | 6,045 | $490.3K | 0.2% | TRIM -47.7% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 63,471 | 143,308 | +125.8% | $11.6M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 32,804 | 42,821 | +30.5% | $3.5M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | ADD | 42,165 | 63,471 | +50.5% | $5.6M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 88,297 | 115,263 | +30.5% | $9.6M | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | ADD | 29,089 | 43,053 | +48.0% | $3.6M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 14,541 | 42,165 | +190.0% | $3.5M | 2025-Q2 |
| UBS Group AG | TRIM | 26,003 | 19,127 | -26.4% | $1.6M | 2025-Q2 |
| CITADEL ADVISORS LLC | ADD | 42,968 | 58,417 | +36.0% | $4.9M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 26,398 | 14,541 | -44.9% | $1.2M | 2025-Q1 |
| FMR LLC | TRIM | 12,250 | 6,412 | -47.7% | $538.0K | 2025-Q1 |
| UBS Group AG | DOUBLED | 6,230 | 23,212 | +272.6% | $2.1M | 2024-Q4 |
| NORGES BANK | EXIT | 98,278 | 0 | -100.0% | $0.00 | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 191,511 | — | $17.8M | 2024-Q3 |
10 unique insiders with 9 transactions. Net insider value: -$8.0M ($0.00 bought, $8.0M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Jasinski Lawrence J | Director | A | 0.466 | $0.00 | $0.00 |
| Jun 4, 2026 | Roush John A | Director | A | 0.466 | $0.00 | $0.00 |
| Jun 4, 2026 | O'Connor John James | Director | A | 0.466 | $0.00 | $0.00 |
| Jun 4, 2026 | SHADAN MARTHA | Director | A | 0.466 | $0.00 | $0.00 |
| Jun 4, 2026 | Pellegrino Joseph P JR | Director | A | 1.824 | $0.00 | $0.00 |
| Jun 4, 2026 | LeBlanc Dorian Paul | Chief Financial Officer | A | 2.476 | $0.00 | $0.00 |
| Jun 4, 2026 | Roberts David B | President and Director | A | 1.824 | $0.00 | $0.00 |
| Jun 4, 2026 | LeMaitre George W | Chairman and CEO | A | 11,974 | $0.00 | $0.00 |
| Jun 4, 2026 | LeMaitre George W | Chairman and CEO | A | 4.009 | $0.00 | $0.00 |
| Jun 4, 2026 | Kamke Trent G | Senior V. P., Operations | A | 0.82 | $0.00 | $0.00 |
| Jun 4, 2026 | LeMaitre George W | Chairman and CEO | G | 11,974 | $0.00 | $0.00 |
| May 8, 2026 | Kamke Trent G | Senior V. P., Operations | SELL | 2,928 | $107.00 | $313.3K |
| May 8, 2026 | LeMaitre George W | Chairman and CEO | SELL | 27,881 | $108.69 | $3.0M |
| May 7, 2026 | Jasinski Lawrence J | Director | M | 1,069 | $0.00 | $0.00 |
| May 7, 2026 | Jasinski Lawrence J | Director | M | 1,069 | $47.19 | $50.4K |
| May 7, 2026 | Jasinski Lawrence J | Director | SELL | 3,943 | $110.00 | $433.7K |
| May 7, 2026 | LeMaitre George W | Chairman and CEO | SELL | 18,600 | $107.64 | $2.0M |
| May 7, 2026 | Ross Bridget A | Director | SELL | 5,044 | $111.10 | $560.4K |
| May 7, 2026 | Ross Bridget A | Director | M | 3,444 | $48.60 | $167.4K |
| May 7, 2026 | Ross Bridget A | Director | M | 3,444 | $0.00 | $0.00 |
| Apr 22, 2026 | Pellegrino Joseph P JR | Director | M | 2,941 | $35.48 | $104.3K |
| Apr 22, 2026 | Pellegrino Joseph P JR | Director | M | 2,941 | $0.00 | $0.00 |
| Mar 26, 2026 | Pellegrino Joseph P JR | Director | A | 1.544 | $0.00 | $0.00 |
| Mar 26, 2026 | Roush John A | Director | A | 0.394 | $0.00 | $0.00 |
| Mar 26, 2026 | O'Connor John James | Director | A | 0.394 | $0.00 | $0.00 |
| Mar 26, 2026 | Ross Bridget A | Director | A | 0.394 | $0.00 | $0.00 |
| Mar 26, 2026 | SHADAN MARTHA | Director | A | 0.394 | $0.00 | $0.00 |
| Mar 26, 2026 | LeMaitre George W | Chairman and CEO | A | 3.392 | $0.00 | $0.00 |
| Mar 26, 2026 | LeBlanc Dorian Paul | Chief Financial Officer | A | 2.095 | $0.00 | $0.00 |
| Mar 26, 2026 | Kamke Trent G | Senior V. P., Operations | A | 0.694 | $0.00 | $0.00 |
| Mar 26, 2026 | Roberts David B | President and Director | A | 1.544 | $0.00 | $0.00 |
| Mar 26, 2026 | Jasinski Lawrence J | Director | A | 0.394 | $0.00 | $0.00 |
| Mar 11, 2026 | Kamke Trent G | Senior V. P., Operations | SELL | 2,625 | $108.50 | $284.8K |
| Mar 11, 2026 | Kamke Trent G | Senior V. P., Operations | M | 2,625 | $0.00 | $0.00 |
| Mar 11, 2026 | Roberts David B | President and Director | SELL | 3,311.68 | $107.68 | $356.6K |
| Mar 11, 2026 | Kamke Trent G | Senior V. P., Operations | M | 2,625 | $35.48 | $93.1K |
| Mar 10, 2026 | LeBlanc Dorian Paul | Chief Financial Officer | F | 96 | $109.20 | $10.5K |
| Mar 10, 2026 | LeBlanc Dorian Paul | Chief Financial Officer | M | 2 | $0.00 | $0.00 |
| Mar 10, 2026 | LeBlanc Dorian Paul | Chief Financial Officer | M | 2 | $0.00 | $0.00 |
| Mar 2, 2026 | LeMaitre George W | Chairman and CEO | G | 5,000 | $0.00 | $0.00 |
| Feb 27, 2026 | Roberts David B | President and Director | SELL | 8,464 | $106.80 | $904.0K |
| Feb 27, 2026 | Kamke Trent G | Senior V. P., Operations | SELL | 1,044 | $110.29 | $115.1K |
| Feb 26, 2026 | Pellegrino Joseph P JR | Director | A | 1,893 | $0.00 | $0.00 |
| Feb 26, 2026 | SHADAN MARTHA | Director | A | 476 | $0.00 | $0.00 |
| Feb 26, 2026 | Roush John A | Director | M | 1 | $0.00 | $0.00 |
| Feb 26, 2026 | SHADAN MARTHA | Director | M | 1 | $0.00 | $0.00 |
| Feb 26, 2026 | Roush John A | Director | A | 476 | $0.00 | $0.00 |
| Feb 26, 2026 | O'Connor John James | Director | A | 476 | $0.00 | $0.00 |
| Feb 26, 2026 | O'Connor John James | Director | M | 1 | $0.00 | $0.00 |
| Feb 26, 2026 | Jasinski Lawrence J | Director | A | 476 | $0.00 | $0.00 |
9 SEC filing reports analyzed. Sentiment: 2 bullish, 2 bearish, 0 mixed, 5 neutral. Avg impact: 4.4/10.
BEARISH
CLUSTER
4/10
Three LeMaitre Vascular insiders, including CEO George LeMaitre, sold a total of $3.0M in open-marke
May 11, 2026
NEUTRAL
CLUSTER
2/10
Three insiders at LeMaitre Vascular sold a total of $1.31M in open-market sales within a week of the
May 11, 2026
NEUTRAL
CLUSTER
3/10
Two directors at LeMaitre Vascular sold a combined $994K in open-market sales on May 7, 2026, follow
May 11, 2026
BULLISH
8-K
7/10
LeMaitre Vascular reported Q1 2026 EPS of $0.68 (+42% YoY), a 3% beat on consensus of $0.66, on reve
May 5, 2026
NEUTRAL
DEFA14A
3/10
LeMaitre Vascular filed a definitive proxy statement for its 2026 Annual Meeting, where shareholders
Apr 14, 2026
NEUTRAL
8-K
3/10
LeMaitre Vascular announced director Bridget Ross will not stand for re-election at the 2026 Annual
Apr 14, 2026
NEUTRAL
CLUSTER
3/10
Multiple LEMAITRE VASCULAR (LMAT) insiders conducted transactions over a 7-day period, including ope
Mar 13, 2026
BEARISH
CLUSTER
7/10
Lemaitre Vascular CEO George LeMaitre sold 150,000 shares for $16.0M in an open-market transaction,
Mar 3, 2026
BULLISH
8-K
8/10
LeMaitre Vascular (LMAT) reported strong Q4 2025 results with revenue of $64.5 million (+16% YoY) an
Feb 25, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (67% buy). Based on 15 analysts: 5 strong buy, 5 buy, 5 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$118.75 mean target
+22.9% upside
Strong Buy (2.11)
$102.00 Low
$135.00 High
| Metric | Value |
|---|---|
| Current Price | $96.59 |
| Target Low | $102.00 |
| Target Mean | $118.75 |
| Target Median | $120.00 |
| Target High | $135.00 |
| # Analysts | 8 |
| Recommendation | Strong Buy (2.11) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.81 | $0.79 | $0.82 | 34.4% | +6.7% | 7↑ 0↓ | $0.1B | 11.3% | 9 |
| Next Q 2026-09-30 |
$0.73 | $0.69 | $0.77 | -2.2% | +1.7% | 3↑ 1↓ | $0.1B | 13.3% | 9 |
| Current FY 2026-12-31 |
$3.00 | $2.93 | $3.05 | 19.0% | +3.4% | 4↑ 0↓ | $0.3B | 12.2% | 9 |
| Next FY 2027-12-31 |
$3.26 | $3.16 | $3.34 | 8.5% | +2.2% | 7↑ 1↓ | $0.3B | 9.2% | 9 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.807 | |
| 7d ago | $0.807 | |
| 30d ago | $0.756 | +0.050 |
| 60d ago | $0.756 | +0.050 |
| 90d ago | $0.754 | +0.052 |
4 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 3, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
| May 6, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
| May 6, 2026 | Citizens | MAINTAIN | Market Outperform | Market Outperform |
| May 6, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 26, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
| Feb 26, 2026 | Roth Capital | REITERATE | Buy | Buy |
| Feb 26, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 26, 2026 | Citizens | MAINTAIN | Market Outperform | Market Outperform |
| Feb 20, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 5 | 5 | 5 | 0 | 0 | 67% | |
| May 1, 2026 | 5 | 6 | 5 | 0 | 0 | 69% | |
| Apr 1, 2026 | 5 | 6 | 5 | 0 | 0 | 69% | |
| Mar 1, 2026 | 5 | 6 | 6 | 0 | 0 | 65% | |
| Feb 1, 2026 | 5 | 6 | 6 | 0 | 0 | 65% | |
| Jan 1, 2026 | 5 | 6 | 6 | 0 | 0 | 65% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 20, 2026
other
LeMaitre to Participate at Upcoming Investor Conferences in June
<p>BURLINGTON, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating i
May 7, 2026
other
LeMaitre to Present at the Bank of America Healthcare Conference
<p>BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Ba
May 5, 2026
dividend
LeMaitre Q1 2026 Financial Results
<p>BURLINGTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and service
May 5, 2026
earnings_calendar
LMAT Q1 2026 Earnings Scheduled — 2026-05-05
Apr 14, 2026
earnings
LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026
<p>BURLINGTON, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarte
Apr 7, 2026
other
LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference
<p align="left">BURLINGTON, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will pre
Mar 25, 2026
short_interest
FTD: LMAT — 4,707 shares ($0.5M) failed to deliver
Settlement: 20260325, Price: $109.99, FTD Value: $517,722.93, LEMAITRE VASCULAR, INC COM
Mar 20, 2026
short_interest
FTD: LMAT — 8,198 shares ($0.9M) failed to deliver
Settlement: 20260320, Price: $109.00, FTD Value: $893,582, LEMAITRE VASCULAR, INC COM
Mar 17, 2026
short_interest
FTD: LMAT — 7,475 shares ($0.8M) failed to deliver
Settlement: 20260317, Price: $110.75, FTD Value: $827,856.25, LEMAITRE VASCULAR, INC COM
Feb 25, 2026
earnings_calendar
LMAT Q4 2025 Earnings After Market Close — 2026-02-25
Feb 24, 2026
short_interest
FTD: LMAT — 5,950 shares ($0.5M) failed to deliver
Settlement: 20260224, Price: $91.38, FTD Value: $543,711, LEMAITRE VASCULAR, INC COM
Feb 18, 2026
short_interest
FTD: LMAT — 8,060 shares ($0.7M) failed to deliver
Settlement: 20260218, Price: $89.25, FTD Value: $719,355, LEMAITRE VASCULAR, INC COM
Feb 17, 2026
short_interest
FTD: LMAT — 18,031 shares ($1.6M) failed to deliver
Settlement: 20260217, Price: $87.66, FTD Value: $1,580,597.46, LEMAITRE VASCULAR, INC COM
Feb 13, 2026
short_interest
FTD: LMAT — 10,689 shares ($0.9M) failed to deliver
Settlement: 20260213, Price: $86.60, FTD Value: $925,667.4, LEMAITRE VASCULAR, INC COM
Feb 11, 2026
short_interest
FTD: LMAT — 10,790 shares ($0.9M) failed to deliver
Settlement: 20260211, Price: $87.98, FTD Value: $949,304.2, LEMAITRE VASCULAR, INC COM